Importantly, past research by our group demonstrated that freshly resected metastatic human melanoma tumors are highly positive for CD47, while its blockade (by administering inhibitory antibodies) led to the significant suppression of melanoma metastases in-vivo using several independently patient-derived xenografts (PDXs) (2). This evidence concerns the gene CD47 and melanoma.